Advanced search
Publication Cover
Leukemia & Lymphoma Volume 52, 2011 - Issue 8
Submit an article Journal homepage
200
Views
14
CrossRef citations to date
0
Altmetric
Letters to the Editor

FcγRIIA and FcγRIIIA polymorphisms do not influence survival and response to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone immunochemotherapy in patients with diffuse large B-cell lymphoma

Anna FabisiewiczDepartment of Molecular BiologyCorrespondence[email protected]
,
Ewa Paszkiewicz-kozikDepartment of Lymphoproliferative Diseases, The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland
,
MichaŁ OsowieckiDepartment of Lymphoproliferative Diseases, The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland
,
Jan WalewskiDepartment of Lymphoproliferative Diseases, The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland
&
Janusz A. SiedleckiDepartment of Molecular Biology
Pages 1604-1606 | Received 02 Mar 2011, Accepted 19 Mar 2011, Published online: 10 Jun 2011

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Tim Illidge, Eleanor J Cheadle, Claire Donaghy & Jamie Honeychurch. (2014) Update on obinutuzumab in the treatment of B-cell malignancies. Expert Opinion on Biological Therapy 14:10, pages 1507-1517.
Read now

Articles from other publishers (13)

Anne Bordron, Marie Morel & Cristina Bagacean. 2024. Resistance to Anti-Cd20 Antibodies and Approaches for their Reversal. Resistance to Anti-Cd20 Antibodies and Approaches for their Reversal 231 247 .
Juan J. Mata-Molanes, Joseba Rebollo-Liceaga, Elena Mª Martínez-Navarro, Ramón González Manzano, Antonio Brugarolas, Manel Juan & Manuel Sureda. (2022) Relevance of Fc Gamma Receptor Polymorphisms in Cancer Therapy With Monoclonal Antibodies. Frontiers in Oncology 12.
Crossref
Jonathan C. Strefford, Malgorzata NowickaChantal E. HargreavesCathy BurtonAndrew DaviesRosalind GandertonWolfgang HiddemannChisako IriyamaWolfram Klapper, Kate V. LathamMaurizio MartelliFarheen MirHelen ParkerKathleen N. PotterMatthew J. J. Rose-Zerilli, Laurie H. SehnMarek Trněný, Umberto Vitolo, Christopher R. BolenChristian Klein, Andrea KnappMikkel Z. OestergaardMark S. Cragg. (2021) Single-nucleotide Fcγ receptor polymorphisms do not impact obinutuzumab/rituximab outcome in patients with lymphoma. Blood Advances 5:15, pages 2935-2944.
Crossref
Matthew J. Barth & Stanton C. Goldman. 2019. Resistance to Targeted Therapies in Lymphomas. Resistance to Targeted Therapies in Lymphomas 27 55 .
Hervé Ghesquières, Beth R. Larrabee, Corinne Haioun, Brian K. Link, Aurélie Verney, Susan L. Slager, Nicolas Ketterer, Stephen M. Ansell, Richard Delarue, Matthew J. Maurer, Olivier Fitoussi, Thomas M. Habermann, Fréderic Peyrade, Ahmet Dogan, Thierry J. Molina, Anne J. Novak, Hervé Tilly, James R. Cerhan & Gilles Salles. (2017) FCGR3A / 2A polymorphisms and diffuse large B-cell lymphoma outcome treated with immunochemotherapy: a meta-analysis on 1134 patients from two prospective cohorts . Hematological Oncology 35:4, pages 447-455.
Crossref
Angela Falduto, Francesco Cimino, Antonio Speciale, Caterina Musolino, Sebastiano Gangemi, Antonella Saija & Alessandro Allegra. (2017) How gene polymorphisms can influence clinical response and toxicity following R-CHOP therapy in patients with diffuse large B cell lymphoma. Blood Reviews 31:4, pages 235-249.
Crossref
Duo Liu, Yuyang Tian, Donglin Sun, Haiming Sun, Yan Jin & Mei Dong. (2016) The FCGR3A polymorphism predicts the response to rituximab-based therapy in patients with non-Hodgkin lymphoma: a meta-analysis. Annals of Hematology 95:9, pages 1483-1490.
Crossref
SAMO ROŽMAN, SRDJAN NOVAKOVIĆ, IZTOK GRABNAR, PETRA CERKOVNIK & BARBARA JEZERŠEK NOVAKOVIĆ. (2016) The impact of FcγRIIa and FcγRIIIa gene polymorphisms on responses to RCHOP chemotherapy in diffuse large B-cell lymphoma patients. Oncology Letters 11:5, pages 3332-3336.
Crossref
Lekh N. Dahal, Ali Roghanian, Stephen A. Beers & Mark S. Cragg. (2015) FcγR requirements leading to successful immunotherapy. Immunological Reviews 268:1, pages 104-122.
Crossref
Tim Illidge, Christian Klein, Laurie H. Sehn, Andrew Davies, Gilles Salles & Guillaume Cartron. (2015) Obinutuzumab in hematologic malignancies: Lessons learned to date. Cancer Treatment Reviews 41:9, pages 784-792.
Crossref
D. Pérez-Callejo, J. González-Rincón, A. Sánchez, M. Provencio & M. Sánchez-Beato. (2015) Action and resistance of monoclonal CD20 antibodies therapy in B-cell Non-Hodgkin Lymphomas. Cancer Treatment Reviews 41:8, pages 680-689.
Crossref
Fen LiuHuirong DingXuan JinNing DingLijuan DengYan HeJun ZhuYuqin Song. (2014) FCGR3A 158V/F Polymorphism and Response to Frontline R-CHOP Therapy in Diffuse Large B-Cell Lymphoma . DNA and Cell Biology 33:9, pages 616-623.
Crossref
Marije B. Overdijk, Sandra Verploegen, Wim K. Bleeker & Paul W.H.I. Parren. 2014. Antibody Fc. Antibody Fc 239 255 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.